Related Experiment Videos
Novel surface tagging technology for selection of complex proliferation-controlled mammalian cell phenotypes
S Schlatter1, J E Bailey, M Fussenegger
1Institute of Biotechnology, Swiss Federal Institute of Technology, ETH Zurich, CH-8093 Zurich, Switzerland.
Biotechnology and Bioengineering
|December 18, 2001
Summary
Engineered Chinese hamster ovary (CHO) cells using p27 and a surface marker enable biphasic production. This method enhances protein production and allows for selection of growth-arrested cells, improving biopharmaceutical manufacturing.
Area of Science:
- Biotechnology
- Cell Biology
- Bioprocessing
Background:
- Biphasic production processes require cell cycle arrest for enhanced product yield.
- Genetic drift can lead to the emergence of unwanted proliferation-competent mutants during arrested phases.
- Cell surface markers offer potential for selecting specific cell phenotypes.
Purpose of the Study:
- To evaluate cell surface markers for ex vivo selection of growth-arrested phenotypes.
- To develop an engineered Chinese hamster ovary (CHO) cell line for improved biphasic production.
- To assess the efficacy of p27 and a novel surface marker (Hook) in cell cycle control and selection.
Main Methods:
- Multigene metabolic engineering of CHO cells to express secreted alkaline phosphatase (SEAP), p27, and Hook.
- Utilizing a tricistronic tetracycline-repressible system for controlled gene expression.
- Employing FACS- or magnetic-based cell sorting for selection of engineered cells.
Main Results:
- The engineered CHO-SS101(5) cell line exhibited p27-mediated G1-phase cell-cycle arrest in the absence of tetracycline.
- SEAP production increased fivefold in arrested CHO-SS101(5) cells compared to proliferation-competent controls.
- Concomitant expression of Hook enabled efficient selection of engineered cells from mixed populations using FACS or magnetic sorting.
Conclusions:
- Regulated p27 expression and surface marker display provide a robust strategy for biphasic bioproduction.
- Ex vivo selection of engineered cells is crucial for maintaining desired phenotypes in biopharmaceutical manufacturing.
- This approach holds promise for applications in gene therapy and tissue engineering requiring in vivo cell maintenance.